Rice Hall James & Associates’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.3M	Buy	608,416 +11,985	+2%	+$531K	1.63%	13
2025 Q4	$24.6M	Buy	596,431 +18,609	+3%	+$746K	1.35%	22
2025 Q3	$22.4M	Sell	577,822 -60,411	-9%	-$1.96M	1.22%	23
2025 Q2	$17.7M	Buy	638,233 +13,688	+2%	+$348K	0.95%	31
2025 Q1	$13.9M	Sell	624,545 -18,207	-3%	-$375K	0.82%	38
2024 Q4	$12.7M	Sell	642,752 -6,878	-1%	-$157K	0.7%	43
2024 Q3	$16.2M	Buy	649,630 +49,000	+8%	+$1.19M	0.88%	29
2024 Q2	$11.2M	Sell	600,630 -18,168	-3%	-$340K	0.67%	44
2024 Q1	$12.2M	Sell	618,798 -17,231	-3%	-$337K	0.7%	41
2023 Q4	$11.2M	Sell	636,029 -14,337	-2%	-$236K	0.65%	44
2023 Q3	$11.3M	Sell	650,366 -9,758	-1%	-$164K	0.72%	41
2023 Q2	$9.29M	Buy	660,124 +4,468	+0.7%	+$59.8K	0.53%	51
2023 Q1	$7.05M	Sell	655,656 -41,506	-6%	-$547K	0.4%	60
2022 Q4	$10.4M	Sell	697,162 -52,771	-7%	-$768K	0.6%	48
2022 Q3	$9.63M	Sell	749,933 -64,740	-8%	-$738K	0.56%	49
2022 Q2	$7.89M	Buy	814,673 +2,751	+0.3%	+$25.7K	0.38%	64
2022 Q1	$8.07M	Buy	811,922 +99,115	+14%	+$1.05M	0.32%	74
2021 Q4	$8.39M	Sell	712,807 -24,567	-3%	-$302K	0.3%	72
2021 Q3	$8.4M	Buy	737,374 +3,008	+0.4%	+$39.2K	0.31%	71
2021 Q2	$10.2M	Buy	734,366 +68,013	+10%	+$1.03M	0.36%	66
2021 Q1	$12.3M	Buy	666,353 +66,836	+11%	+$1.37M	0.4%	61
2020 Q4	$10.6M	Buy	+599,517	New	+$10.5M	0.37%	62